Le Lézard
Classified in: Health, Business
Subject: TNM

Kansas City Dermatology Joins Epiphany Dermatology


AUSTIN, Texas, Nov. 12, 2019 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its national presence into Kansas through its partnership with Kansas City Dermatology. 

(PRNewsfoto/CI Capital Partners)

Founded in 1987 by Mark McCune, MD, Kansas City Dermatology has a long-established reputation of providing high-quality dermatology services to patients in the greater Kansas City market.  Dr. McCune is a board-certified dermatologist who earned his medical degree at the University of Kansas School of Medicine and completed his dermatology residency at Mayo Graduate School of Medicine. 

Dr. McCune commented, "My staff and I are excited to join Epiphany, which has proven itself to be a high-quality company comprised of caring dermatologists.  Epiphany shares the values and goals that my staff and I believe in ? providing excellent care across the entire spectrum of medical, surgical, and cosmetic dermatologic needs. By forming this partnership with Epiphany, we will expand our ability to treat skin conditions and cancers in our community.  Epiphany has the infrastructure to help us manage the growing regulatory burdens that have the potential to interfere with our ability to focus on what matters most ? taking care of our patients and serving our community."   

Gheorghe Pusta, Co-Founder and Chief Executive Officer of Epiphany, said, "We are pleased to welcome Dr. McCune and his staff to Epiphany.  Through our interactions with Dr. McCune, we were impressed with his commitment to clinical excellence across a variety of service lines, including a robust clinical research program.  He and his team are dedicated to improving access to care in the greater Kansas City market.  This is a nice opportunity for Epiphany to expand our provider network and improve access to exceptional dermatologic care in Kansas."

Through this partnership, Kansas City Dermatology's providers and staff gain additional resources to help with operations, managed care, marketing, compliance, human resources, recruiting, IT, and many other support services. 

About Epiphany Dermatology

Epiphany Dermatology is a rapidly expanding dermatology company, driven by a passion to improve access to exceptional dermatologic care in a values-based manner. Through its partnership with leading dermatologists across 48 locations in Arizona, Colorado, Iowa, Kansas, Minnesota, Missouri, New Mexico, Oklahoma, and Texas, Epiphany provides general dermatology, skin cancer care, Mohs surgery, cosmetic services, and additional dermatologic services.  Epiphany raises the standard of dermatology care by making clinical excellence accessible to all patients, promptly and in a warm and inviting environment.  Epiphany Dermatology is headquartered in Austin, Texas.  For more details, please visit www.epiphanydermatology.com or call (512) 628-0465.

Ted Emmert
Chief Development Officer
Epiphany Dermatology 
(512) 628-0465
temmert@epiphanydermatology.com

Gheorghe Pusta
Chief Executive Officer
Epiphany Dermatology
(512) 628-0465
gpusta@epiphanydermatology.com

SOURCE CI Capital Partners


These press releases may also interest you

at 15:44
Canopy Growth Corporation ("Canopy Growth" or the "Company") is pleased to announce that effective January 14, 2020, David Klein has been appointed as the Company's Chief Executive Officer. David brings a wealth of...

at 15:41
Montreal's innovation professionals are coming together to provide an advanced technological solution to help care more effectively for patients with heart failure and multiple other conditions such as diabetes. Called...

at 15:36
The Accreditation Council for Graduate Medical Education's (ACGME's) Clinical Learning Environment Review (CLER) Program is pleased to announce the publication of Version 2.0 of its CLER Pathways to Excellence: Expectations for an Optimal Clinical...

at 15:30
The Financing and Reimbursement of Cures in the US Consortium (FoCUS) launched the Paying for Cures Toolkit today. The free online resource helps payers, patient advocates, drug developers, policymakers, and other healthcare system stakeholders...

at 15:24
Canada's largest union, the Canadian Union of Public Employees (CUPE), is calling on Prime Minister Justin Trudeau to restore federal health funding increases through the Canada Health Transfer (CHT) to 2016 levels. CUPE...

at 15:21
Portola Pharmaceuticals, Inc.® today announced new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an investigational, oral SYK/JAK inhibitor, in patients with relapsed/refractory follicular lymphoma (FL) receiving...



News published on 12 november 2019 at 11:01 and distributed by: